Mackay Shields LLC Travere Therapeutics, Inc. Transaction History

Mackay Shields LLC

  • $499 Million
  • Q4 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 13, 2021
SELL
$14.11 - $26.4 $591,589 - $1.11 Million
-41,927 Closed
0 $0
Q1 2021

May 14, 2021
SELL
$23.37 - $31.77 $728,513 - $990,366
-31,173 Reduced 42.64%
41,927 $1.05 Million
Q4 2020

Feb 16, 2021
BUY
$19.17 - $27.87 $1.4 Million - $2.04 Million
73,100 New
73,100 $1.99 Million

Others Institutions Holding TVTX

# of Institutions
203
Shares Held
85.1M
Call Options Held
776K
Put Options Held
912K
View Full List

About Travere Therapeutics, Inc.

TVTX Quotes by TradingView
  • Ticker TVTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 64,173,600
  • Market Cap $1.35B
  • Description
  • Travere Therapeutics, Inc., a biopharmaceutical company, focuses on the identification, development, commercialization, and delivering of therapies for the treatment of rare diseases. Its marketed products include Chenodal, a synthetic oral form of chenodeoxycholic acid for the treatment of radiolucent stones in gallbladders; Cholbam, a cholic a...
More about TVTX
Track This Portfolio

Track Mackay Shields LLC Portfolio

Follow Mackay Shields LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mackay Shields LLC, based on Form 13F filings with the SEC.

News

Stay updated on Mackay Shields LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email